Finally, the pieces of the puzzle start to add up. Last week, President Bush sought to instill panic in this country by telling us a minimum of 200,000 people will die from the avian flu pandemic but it could be as bad as 2 million deaths in this country alone.
This hoax is then used to justify the immediate purchase of 80 million doses of Tamiflu, a worthless drug that in no way shape or form treats the avian flu, but only decreases the amount of days one is sick and can actually contribute to the virus having more lethal mutations.
So the U.S. placed an order for 20 million doses of this worthless drug at a price of $100 per dose. That comes to a staggering $2 billion.
We are being told that Roche manufactures Tamiflu and, in yesterday's New York Times, they were battling whether or not they would allow generic drug companies to help increase their production.
But if you dig further you will find that a drug was actually developed by a company called Gilead that 10 years ago gave Roche the exclusive rights to market and sell Tamiflu.
Ahh, The Plot Thickens...
If you read the link below from Gilead, you'll discover Defense Secretary Donald Rumsfeld was made the chairman of Gilead in 1997.
Since Rumsfeld holds major portions of stock in Gilead, he will handsomely profit from the scare tactics of the government that is being used to justify the purchase of $2 billion of Tamiflu.
For more on the nonsense of the avian flu hoax, you'll want to read my new book, The Great Bird Flu Hoax: The Truth They Don't Want You to Know About the "Next Big Pandemic". This book explains in a clear and compelling manner the real science that proves this is indeed the biggest hoax of our time.
More importantly, The Great Bird Flu Hoax exposes what you should REALLY be worried about (truths that have a profound impact on the health and safety of you and your loved ones) and provides you with health solutions to optimize your immune system ... so you need not worry about bird flu hype or about the real health threats such as cancer, heart disease and other genuine health issues.
Gilead Sciences Inc.